Efficacy and Safety of TAC and Exemestane as Neoadjuvant Chemotherapy in the Postmenopausal Women With Breast Cancer

NCT01648608 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
600
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Tianjin Medical University